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To understand how protein-protein interactions mediated by the Src-SH3 domain affect c-Src signaling, we 
screened for proteins that interact with the Src-SH3. We found a novel protein. Sin (Src interacting or signal 
integrating protein), that binds to Src-SH3 with high affinity, contains numerous tyrosine residues in 
configurations suggestive of SH2-binding sites, and is related to the v-Src substrate pi30*^ ^^ . In cotransfection 
assays, a small fragment of Sin retaining the Src-SH3-binding site and one tyrosine-containing motif induced 
c-Src activation as measured by a transcriptional reporter. Phosphorylation of the peptide on tyrosine by c-Src, 
as a consequence of Src-SH3 binding, was necessary for its stable interaction with c-Src in vivo and for 
transcriptional activation. Phosphorylation of multiple tyrosine-containing motifs found on Sin correlated 
with c-Crk and cellular phosphoprotein binding to Sin as well as increased c-Src activity. These data suggest 
that (1) SH2 and SH3 ligand sites on Sin cooperatively activate the signaling potential of c-Src, (2) Sin acts as 
both an activator and a substrate for c-Src, and (3) phosphorylated Sin may serve as a signaling effector 
molecule for Src by binding to multiple cellular proteins. 
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Src was discovered as an oncoprotein that had constitu­
tive tyrosine kinase activity (Brugge and Erickson 1977; 
Hunter and Sefton 1980; Sefton et al. 1980). The normal 
cellular c-Src, however, has a regulated kinase activity 
that can be activated by removing an autoinhibitory in­
teraction in the protein (Cooper and King 1986; Cart-
wright et al. 1987; Kmiecik and Shalloway 1987; Pi-
wnica-Worms et al. 1987). The inhibited state is thought 
to be achieved through an intramolecular interaction in 
which the carboxy-terminal tail of c-Src interacts with 
the amino-terminal SH3 and SH2 domains (Roussel et al. 
1991; Liu et al. 1993; Murphy et al. 1993; Okada et al. 
1993; Superti et al. 1993; Bagrodia et al. 1994). That in­
teraction depends on phosphorylation of Src tyrosine 527 
by the Csk kinase (Nada et al. 1991; Okada et al. 1991). 
The phosphorylated tyrosine must interact with SH2, 
but the binding site for SH3 remains uncertain. A 
dimeric complex of the tyrosine-phosphorylated car­
boxy-terminal tail of Lck—a kinase related to Src—with 
its SH2 and SH3 domains has been crystalized and its 
structure determined, but its direct relevance to Src re­
mains uncertain (Eck et al. 1994). Ligands for the Src-
SH2 domain, such as tyrosine-phosphorylated motifs 
found on activated platelet-derived growth factor (PDGF) 
receptors, can activate Src enzymatic activity in vitro by 
^Corresponding author. 
outcompeting intramolecular inhibitory interactions 
(Liu et al. 1993). Changes in the phosphorylation state of 
tyrosine 527 by mutation (Kmiecik and Shalloway 1987; 
Piwnica-Worms et al. 1987), association with polyoma 
mT antigen (Cartwtight et al. 1987), or antibody binding 
(Cooper and King 1986), can also activate the c-Src ki­
nase. 
SH3 and SH2 domains are modular polypeptide units 
that mediate protein-protein interactions and are parts 
of many cytoplasmic signaling proteins. Structures of 
both domains have been solved from a variety of proteins 
and their ligand specificities have been determined (Co­
hen et al. 1995). SH2 domains bind to phosphotyrosine-
containing sequences (Anderson et al. 1990; Mayer et al. 
1991), whereas SH3 domains recognize proline-rich pep­
tides with a PXXP core motif (Ren et al. 1993; Yu et al. 
1994). Ligands can bind to SH3 domains in either an 
amino-carboxy or a carboxy-amino orientation and are 
therefore classified as class I or class II, respectively 
(Feng et al. 1994). SH2 and SH3 domains mediate a va­
riety of physiological responses and are found together 
on many proteins (Cohen et al. 1995), suggesting that 
their activities may be coordinated. Identification of 
physiological regulators of the enzymatic activity of Src 
and its substrates has proved difficult. In recent years, a 
number of proteins have been identified that associate 
with v-Src through its modular SH2 and SH3 domains, 
although the biological role of these interactions is not 
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clear. Among the proteins identified are ones that con­
tain multiple ligands for the Src-SH2 and Src-SH3 do­
mains—pl30^^" (Sakai et al. 1994), paxillin (Weng et al. 
1993), and p62/Sam68 (Taylor and Shalloway 1994; 
Richard et al. 1995; Taylor et al. 1995; Lock et al. 1996)— 
suggesting a cooperative role for these domains in Src 
regulation. Therefore, it has been proposed that these 
proteins, when phosphorylated on tyrosines, can act as 
signal integration sites by forming multiprotein com­
plexes with cytoplasmic SH2-containing proteins. Such 
a role would be equivalent to that had by the insert and 
tail components of tyrosine kinase-containing surface re­
ceptor proteins like the PDGF receptor (Kazlauskas and 
Cooper 1989; Courtneidge et al. 1991; Fantl et al. 1992; 
Ronnstrand et al. 1992; Valius et al. 1993), and this 
mechanism could be used to propagate signals through 
the cytoplasm. 
In this paper we describe a novel protein, Sin, that 
contains two ligand sites that exhibit high-affinity bind­
ing for Src-SH3, as well as multiple tyrosine-containing 
motifs that could bind to SH2 domains. We show that on 
binding to Src-SH3, Sin activates c-Src kinase activity 
and becomes highly tyrosine-phosphorylated. Both 
events are required for stable association of Src with Sin 
and subsequent signaling through Src. In addition, we 
show that an increased number of Sin tyrosine-contain­
ing motifs correlates with increased phosphorylation and 
increased gene expression, as well as with c-Crk associ­
ation, suggesting that Sin may serve as a signal-integrat­
ing molecule in Src signal transduction. 
Results 
Isolation of Sin 
We have described previously the isolation of novel pro-
line-rich sequences from a mouse embryonic library that 
bind to SH3 domains with different specificities (Alex-
andropoulos et al. 1995). One such clone (10a) bound 
specifically to Src-SH3 with high affinity using an 
RPLPALP motif. This binding specificity for Src-SH3 
was consistent with results from phage display (Rickles 
et al. 1994) or selection from chemically synthesized li­
braries (Yu et al. 1994). A 2.2-kb c-DNA clone was iso­
lated from a mouse embryonic cDNA library using a 5' 
fragment of clone 10a as a probe. This clone encodes a 
predicted 560-amino-acid protein we have called Sin (for 
Src interacting or signal integrating protein) (Fig. lA). 
This clone shares regions of homology with the recently 
isolated pl30*^^^ (Fig. IB), a bigger protein that is highly 
phosphorylated in v-Src and v-Crk transformed cells (Sa­
kai et al. 1994). Sin and pl30^^^ contain 84% homolo­
gous (66% identical) amino-terminal SH3 domains, and 
their carboxyl termini are 57% homologous (42% iden­
tical) over a stretch of 134 amino acids. In addition, both 
proteins have a central substrate region (Sakai et al. 
1994) that contains repeated tyrosine motifs, although 
the number and primary sequences of these motifs differ 
between the two proteins (Table 1). The overall architec­
ture of mouse Sin and rat pl30'^''* are similar, but the 
DNA sequences encoding these proteins are not homol­
ogous outside of the regions coding for the amino-termi­
nal SH3s and the carboxyl termini; we therefore believe 
that these proteins are possibly related members of a 
novel family of proteins, rather than homologs from dif­
ferent species. The molecular cloning and definition of 
the expression patterns of Sin were recently discovered 
independently (Ishino et al. 1995). 
Regulation of c-Src by a Sin peptide 
Because Sin contains two high-affinity class I Src-SFi3-
binding sites (Alexandropoulos et al. 1995; Fig. lA), we 
believed that it might be involved in the regulation of 
c-Src. For instance, its binding could interfere with the 
SH3-mediated intramolecular control of c-Src and acti­
vate signaling by the c-Src kinase domain. To test such 
possibilities, we have examined the interaction of por­
tions of Sin with Src-SH3. Initially, we used a 92-amino-
acid fragment of Sin (plOa-92) (sequence in Fig. IC). Ex­
tracts of 293 cells overexpressing c-Src were incubated 
with purified glutathionine S-transferase (GST)-pl0a-92 
fusion protein coupled to glutathione beads, or with anti-
Src antibody, and the captured proteins were revealed by 
in vitro kinase assays. The antibody bound no detectable 
protein from control cells but recovered Src as a phos­
phorylated band from cell lysates overexpressing c-Src 
(Fig. IC, lanes 1,2). The pIOa-92 peptide also bound to 
c-Src and served as a very efficient substrate for the c-Src 
kinase (Fig. IC, lanes 4,5). In contrast, a peptide that 
specifically binds to Abl-SH3 (clone lOg; Alexandropou­
los et al. 1995) did not precipitate c-Src (Fig. IC, lane 6). 
As seen for c-Src, plOa-92 was bound to and phosphory­
lated by the constitutively activated c-SrcY527Y mutant 
(Fig. IC, lanes 3,7-9). These data suggested that the Src-
SH3-binding sequence present on plOa-92 could bind to 
Src-SH3 in solution and serve as a substrate for c-Src. 
To test the ability of the plOa-92 peptide to modulate 
c-Src signaling in cells, we used a transient expression 
protocol with retroviral vectors expressing c-Src or 
c-SrcY527F (Kmiecik and Shalloway 1987). Signaling by 
the overexpressed proteins was assessed by activation of 
a cotransfected reporter luciferase construct containing 
four serum response elements that regulate the expres­
sion of the primary response transcription factor Egr-1 
(Fig. 2A) (Tsai-Morris et al. 1988). These elements were 
shown previously to mediate activation of Egr-1 tran­
scription in response to v-Src (Qureshi et al. 1991). Over-
expression of c-Src had a barely detectable effect on lu­
ciferase activation as expected, attributable to the in­
tramolecular negative regulation of the kinase by its 
phosphorylated carboxy-terminal tail (Superti et al. 
1993) (Fig. 2A). In contrast, the transforming derivative 
c-SrcY527F stimulated luciferase activity in proportion 
to the amount of DNA transfected into 293 cells (Fig. 
2A). Neither the empty vector (pEVX; Fig. 2A) nor a lu­
ciferase construct lacking the SRE-containing promoter 
displayed stimulated luciferase activity (data not 
shown). The various Src proteins were expressed at sim­
ilar levels (data not shown). 
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Figure 1. Structure of Sin and interaction 
of its proline-rich peptide plOa-92 with 
c-Src in vitro. [A] Amino acid sequence en­
coded by the 2.2-kb c-DNA clone of Sin. 
Sin contains an amino-terminal SH3 do­
main (small, boldface letters), 12 tyrosine 
containing motifs (boxed), two high-affin­
ity class I Src-SH3 ligands (shaded), and a 
carboxy-terminal region homologous to 
that of pl30^^" (underscored). [B] Sche­
matic representation of pl30^^^ Sin, and 
plOa-92. (SR) The substrate region that 
contains the tyrosine motifs; (stars) class I 
Src-SH3 binding sites; (C) carboxy-termi­
nal region of homology between Sin and 
pl30'^^'. plOa-92 is a fragment of Sin 
(amino acids 244-335) that contains one 
Src-SH3 binding site (star), and one tyro-
sine-containing motif (Y). (C) In vitro inter­
action of a Sin peptide with c-Src. Cell ex­
tracts were prepared from either untrans-
fected 293 cells (U) or cells transfected 
with vectors encoding c-Src or c-SrcY527F. 
The extracts were incubated with either 
anti-Src mAb327 (IP) (lanes 1-3), or GST-
plOa-92 [top] expressed in bacteria, puri­
fied, and coupled to glutathione-agarose 
(in duplicate lanes 4,5,7,8] or GST-lOg 
(lanes 6,9). Protein complexes were washed 
and reacted in vitro with l7--^ ^P]ATP. Au-
tophosphorylated Src proteins and Src-
phosphorylated plOa-92 fusion protein are 
indicated. 
We then tested the effect of plOa-92 on c-Src and 
c-SrcY527F in cotransfection assays, using a eukaryotic 
expression vector encoding plOa-92 as a GST fusion pro­
tein. The GST-plOa-92-expressing plasmid produced an 
almost 10-fold increase in luciferase activity compared 
with GST alone (Fig. 2B, lanes 7,8). No luciferase stim­
ulation v^as observed in experiments using pEVX, the 
empty vector for expressing Src, or the kinase inactive 
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Table 1. Sequence comparison of Y motifs on Sin 
andpiaO^"' 
Sin pl30^ 
Y V I P 
Y KVP 
YDV P 
YDS P 
YDVP 
Y AAP 
Y E AP 
YDVP 
YGGL 
Y EG I 
YDYV 
Y VHL 
YDNV 
YLVP 
YQAP 
YQVP 
YQVP 
YQVP 
YDTP 
YDVP 
YDTP 
YDVP 
YDVP 
YDVP 
YDVP 
YDVP 
YDVP 
YAVP 
YDYV 
SrcK295R (Fig. 2B, lanes 2,14), suggesting that the in­
crease in luciferase activity was attributable to the ki­
nase activity of overexpressed c-Src. 
Use of mutated peptides 
Because plOa-92 was isolated by its ability to bind to 
Src-SH3, we tested the role of the RPLPALP motif in 
c-Src-induced luciferase activation. To this end, the argi-
nine of the plOa-92 peptide was mutated to an alanine. 
When this mutant was coexpressed with c-Src in 293 
cells, we found no induction of luciferase activity (Fig. 
2B, lane 9), showing that for the plOa-92 peptide to in­
duce c-Src-mediated luciferase activity, the RPLPALP 
motif must be intact. This result clearly suggests that 
plOa-92 activates by binding to Src-SH3. However, a 
construct expressing the RPLPALP motif as part of a pep­
tide consisting of only the carboxy-terminal 18 amino 
acids of plOa-92 (Alexandropoulos et al. 1995) failed to 
induce luciferase activity when cotransfected with c-Src 
(Fig. 2B, lane 12). This suggests that binding of a ligand to 
Src-SH3 may be necessary but is certainly not sufficient 
for signaling, and that additional elements on the longer 
peptide are involved. 
A previous experiment showed that pIOa-92 can be 
phosphorylated by c-Src in vitro (Fig. IC), suggesting that 
this phosphorylation could be involved in the intracel­
lular Src-mediated signaling. Because this peptide con­
tains a single tyrosine for phosphorylation—apart from 
the tyrosines in the linked GST—we tested the require­
ment for this tyrosine by introducing a tyrosine to phe­
nylalanine substitution in the plOa-92 peptide. This mu­
tation greatly diminished the ability of this peptide to 
induce c-Src-mediated activation of luciferase (Fig. 2B, 
lane 10). An arginine to alanine and tyrosine to phenyl­
alanine double mutant was totally inactive (Fig. 2B, lane 
11). All constructs expressed similar levels of GST-
linked peptide (Fig. 2B, inset). The wild-type and mutant 
plOa-92 peptides had no effect on the already activated 
c-SrcY527F mutant (Fig. 2C). The luciferase activity 
stimulated by c-Src in the presence of plOa-92 was three 
to fourfold less than the constitutive activity observed 
with c-SrcY527F. 
In vivo association of c-Sic and the Sin peptide 
We then examined whether plOa-92 associated with 
c-Src in vivo. The wild-type and mutant plOa-92 proteins 
were cotransfected with either c-Src or c-SrcY527F into 
293 cells under conditions identical to those used for the 
luciferase activation experiments (see Materials and 
methods). Src proteins were immunoprecipitated with 
mAb327 and immune complexes were assayed in vitro 
for Src kinase activity. We found that the wild-type plOa-
92 peptide coprecipitated with, and was phosphorylated 
in vitro by, both c-Src and the activated c-Src mutant 
(Fig. 3A, lanes 2,7), whereas no detectable association 
was observed with any of the plOa-92 mutants (Fig. 3A, 
lanes 3,4,8,9). Probing of the blot with a polyclonal anti-
GST serum also showed interaction only with the wild-
type peptide (Fig. 3B). In parallel experiments using 
c-Abl, we were unable to detect any association between 
it and the different plOa-92 peptides in either kinase as­
says or using the GST antiserum (Fig. 3A,B; lanes 10-15) 
suggesting that the interaction of the peptide with Src is 
specific. Wild-type and mutant Src proteins were ex­
pressed at similar levels as shown by anti-Src immuno-
blots (Fig. 3C). These data show that for c-Src to strongly 
interact with the Sin peptide, both its SH3 and SH2 
ligand sites must be intact, implying a cooperative bind­
ing. 
A portion of the c-Src molecules exhibited retarded 
electrophoretic mobility when coexpressed with the 
wild-type plOa-92 peptide (Fig. 3A, lane 2). The phospho-
Figure 2. Activation of Src signaling by Sin peptide. [A] Activation of SRE-luciferase reporter construct by different Src proteins. 
Schematic representation of the SRE-containing luciferase construct shown above. Plasmid DNAs containing either an empty retro­
viral expression vector (pEVX), a vector with inserts coding for c-Src, or c-SrcY527F proteins were transfected transiently into 293 cells 
at the indicated amounts. Data for each concentration were averaged from actual luminometer values of least three separate exper­
iments; values shown are the mean ±S.D. [B] Vector (pEVX) plasmid DNA, DNA expressing c-Src, or the c-Src kinase mutant K295R 
were cotransfected into 293 cells with 1 |xg of DNA expressing either wild-type or mutant plOa-92 proteins. Fold activation is relative 
to the activation of the luciferase in cells cotransfected with c-Src and wild-type plOa-92 that was given a value of 10 (actual increase 
8.5±0.86, n = 6). The data from several experiments [n>5) were averaged and values shown are the mean with an indicated s.D. (C) 293 
cells were cotransfected with the activated c-SrcY527F mutant and wild-type and mutant plOa-92 peptides as in B. Fold activation is 
expressed as relative to that observed with c-Src and wild-type piOa-92 in Fig. 2B (lane 8). Data were averaged from at least four separate 
experiments and values shown are the mean and s.D. 
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Figure 3. Interaction of plOa-92-derived peptides 
with c-Src in vivo. (A) Cell extracts were prepared 
from cells overexpressing c-Src, activated 
c-SrcY527F, or c-Abl (-) and wild-type or mutant 
plOa-92 peptides, as shown. The transfection con­
ditions used were identical to those used for Fig. 
2B. Extracts were immunoprecipitated with Src 
mAb327 or Abl mAb-3 and immune complexes 
were incubated for Src kinase activity in vitro. 
Phosphorylated proteins were separated on SDS-
PAGE and transferred to nitrocellulose. Autora-
diographs were obtained by exposing the blots for 
1 hr at room temperature. Results are representa­
tive of several independent experiments. [B] The 
blots from 3A were immunoblotted with a rabbit 
polyclonal antiserum to GST, and visualized by 
enhanced chemiluminescent detection jECL, Am-
ersham). Exposures were performed for 15 sec and 
no background exposure from the radioactive pro­
teins was observed under these conditions. (C) Al-
iquots of total cell extracts from A, containing 
overexpressed c-Src of c-SrcY527F, were normal­
ized for protein content and immunoblotted with 
anti-Src mAb327. 
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rylation pattern of the constitutively active c-SrcY527F 
mutant showed both the retarded and unretarded forms, 
irrespective of the presence or absence of the different 
peptides (Fig. 3A, lanes 6-9). c-Src hyperphosphorylation 
and a concommitant mobility shift of a small percentage 
of Src molecules has been observed in other situations of 
c-Src activation, such as during mitosis (Kypta et al. 
1990; Bagrodia et al. 1991; Taylor and Shalloway 1994). 
Lack of stable association of the mutant peptides v^ith 
c-Src correlates with the inability of these proteins to 
induce signaling through c-Src (Fig. 2B). It appears that 
both the Src-SH3 ligand present on the plOa-92 peptide 
and its DEGIYDVP tyrosine are required for activation 
and stable in vivo association of this peptide with c-Src. 
In vitro activation of c-Src 
To show further that plOa-92 can directly activate c-Src, 
we assayed the effect of purified^ bacterially expressed, 
GST-plOa-92 fusion proteins on c-Src autophosphoryla-
tion in vitro. Extracts from transfected 293 cells overex­
pressing c-Src and c-SrcY527F, were immunoprecipi­
tated with Src mAb327. When immune complexes con­
taining c-Src were incubated with purified GST-plOa-92, 
a plOa-92-dependent increase of c-Src autophosphoryla-
tion was observed, which also caused a partial decrease 
in Src mobility (Fig. 4A, lane 3). In contrast, no change of 
mobility occurred with the c-SrcY527F mutant (Fig. 4A, 
lanes 6-9). Autophosphorylation of c-SrcY527F was 
lower than that observed with c-Src. This difference may 
have been attributable to a lower substrate concentra­
tion because tyrosine 416 was already phosphorylated in 
the mutant protein. To examine this question, the blots 
were reprobed with a polyclonal antiserum that specifi­
cally recognizes the phosphorylated form of SrcY416 but 
not the nonphosphorylated Y4I6 or other phosphory­
lated tyrosines (Fig. 4B) (Mukhopadhyay et al. 1995; S. 
Iyer, R. Russel, K. Flynn, D. Shalloway, and A. Laudano, 
in prep.). Although the in vitro phosphorylation levels of 
c-SrcY527F were lower than those of c-Src (Fig. 4A, lanes 
2,6), tyrosine 416 phosphorylation was higher in 
c-SrcY527F (Fig. 4B, lanes 2,6). Furthermore, the in­
creased autophosphorylation activity of c-Src induced by 
plOa-92 correlated with an increased Y416 level (Fig. 4B, 
lane 3), showing that the peptide markedly increases the 
autophosphorylation activity of c-Src. 
Src did phosphorylate the plOa-92 peptide when it was 
presented in vitro (Fig. 4A, lane 3). Enolase, a classic Src 
substrate, did not show any increased phosphorylation 
when the peptide was present perhaps because the pep­
tide blocked access to the c-Src catalytic site. In fact, 
c-SrcY527F phosphorylated enolase less efficiently when 
the peptide was present (Fig. 4A, cf. lanes 6 and 7). An 
arginine to alanine substitution in the RPLPALP motif 
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greatly diminished the abiUty of c-Src to phosphorylate 
GST-plOa-92 (Fig. 4A, lane 4). The small amount of 
phosphorylation observed with the alanine mutant may 
be attributable to low-affinity binding of the mutant pep­
tide to Src-SH3, as this peptide can still bind weakly to 
Src-SH3 when tested in filter-binding assays (Fig. 4C, 
left). The residual binding activity of the mutant peptide 
may be caused by the presence of another arginine resi­
due immediately upstream of the arginine in the 
RPLPALP motif (Fig. lA), although any low-affinity in­
teraction of this residue with Src-SH3 is not sufficient to 
induce signaling by c-Src (Fig. 2B). 
The requirement for a wild-type SH3-binding site on 
plOa-92 suggests that binding of this peptide to Src-SH3 
precedes and is necessary for Src-kinase activation and 
subsequent phosphorylation of the peptide by c-Src. A 
protein containing a tyrosine to phenylalanine substitu­
tion in the DEGIYDVP did not increase c-Src autophos-
phorylation or phosphorylation of enolase (Fig. 4A, lane 
5). The mutant peptide bound to Src-SF13 (Fig. 4C, left) 
but was not phosphorylated, suggesting that the mutated 
tyrosine is the only site being phosphorylated by Src. 
The inability of the tyrosine mutant to activate c-Src in 
vitro correlated with a lack of c-Src-mediated signaling 
as shown in luciferase assays (Fig. 2B), and suggests that 
although binding of a peptide to Src-SH3 is necessary for 
subsequent signaling events, it is not sufficient for acti­
vation of Src. 
Activity of longer segments of Sin 
Thus far, only the effects of a short fragment of Sin have 
been discussed. To extend the analysis, we generated 
Sin-SR (Fig. 5A), a construct that added to plOa-92 pep­
tide other tyrosine-containing motifs found upstream of 
the SH3-binding site but not Sin-SH3. When this con­
struct was tested for c-Src-dependent luciferase activa­
tion, it was more than twofold as active as plOa-92 (Fig. 
5A, cf. lanes 9 and 10). Cotransfection of a construct that 
included Sin-SH3 (SinAC; Fig. 5A) was even more effec­
tive, giving an —35-fold overall effect on luciferase ac­
tivity (Fig. 5A, lane 8). Expression of the full-length pro­
tein (Sin; Fig. 5A) had, at most, a slightly greater effect on 
luciferase activation by c-Src. Addition of the second 
Src-SFi3-binding site to SinAC had no additional effect 
(data not shown). The effect on luciferase activation ob­
served with the longer Sin constructs was almost equiv­
alent to that observed with the transforming c-SrcY527F 
mutant, and no further activation was observed when 
any of the Sin constructs was cotransfected with 
c-SrcY527F (Fig. 5A, lanes 11-15). Luciferase activation 
was c-Src-dependent because no activation was observed 
with the c-Src kinase-inactive mutant (data not shown). 
The SinAC, Sin-SR, and Sin constructs formed stable 
complexes with c-Src in vivo as shown by anti-Src im-
munoprecipitations and subsequent in vitro kinase as­
says (Fig. 5B). No complexes were detected when Sin 
constructs were cotransfected with the kinase-inactive 
Src mutant (data not shown). Results similar to those 
with wild-type c-Src were obtained with the c-SrcY527F 
C-Src c -SrcY527F 
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Figure 4. Phosphorylation of plOa-92 derivatives by c-Src in 
vitro. [A] Lysates of 293 cells expressing equal amounts of trans-
fected c-Src or c-SrcY527F were immunoprecipitated with 
mAb327, and immune complexes were washed and assayed for 
Src kmase activity. Supernatants from several transfected plates 
overexpressing either c-Src or c-SrcY527F were pooled and the 
two supernatants were normalized to each other for protein 
content. Aliquots for each lane were taken from the same su­
pernatant expressing either c-Src or c-SrcY527F to ensure that 
all lanes contained the same amount of overexpressed Src pro­
teins, and all the samples were processed identically. Reactions 
were carried out in the presence of 5 |jLg of acid-denatured eno­
lase (Sigma) and 1 |xg of purified GST-plOa-92 wild-type or mu­
tant proteins (made in bacteria) that were added in the reaction 
buffer. The samples were processed as in Fig. 3A. Autoradio-
graphs were obtained by exposing the nitrocellulose membranes 
for 30 min at room temperature. [B] The blots from A were 
immunoblotted with a polyclonal antiserum against Y416 of 
c-Src and bands visualized as in Fig. 3B. Exposures were per­
formed for 15 sec. [C] Equal amounts of proteins purified from 
bacteria were analyzed by electrophoresis, and either stained 
with Coomassie blue [right panel, 1 jig of protein per lane), or 
transferred to nitrocellulose membranes [left panel, 0.1 M-g of 
protein per lane). Filter binding assays were performed as de­
scribed (Alexandropoulos et al. 1995) using biotinylated Src-
SH3 as probe {left panel). 
mutant (data not shown), confirming again that tight 
binding of Sin to c-Src requires both the SH3- and SH2-
binding sites on Sin. An increased number of potentially 
phosphorylated motifs correlated with increased 
amounts of phosphorylation and increased signaling (Fig. 
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Figure 5. Sin and deleted variants of it in­
duce c-Src-dependent luciferase activity 
and associate with c-Src in vivo. [A] Sche­
matic representation of the different Sin-
truncated proteins. Sin full-length se­
quence is as shown on Fig. 1 A. SinAC lacks 
the carboxy-terminal region. Sin-SR is 
plOa-92 peptide plus the entire substrate 
region (SR). Both of these proteins termi­
nate at the same residue at their carboxyl 
terminus as the plOa-92 peptide (Fig. IC). 
293 cells were transfected as in Fig. 2B with 
pEVX vector or a vector expressing differ­
ent Src proteins as indicated, along with 
plasmids expressing GST, or GST-fusion 
proteins of truncated versions of Sin. Fold 
activation is relative to the activation of 
the luciferase in cells cotransfectd with 
c-Src and GST that was given a value of 1. 
The data from several experiments (n>3) 
were averaged and values shown are the 
mean and s.D. [B] Cell extracts transfected 
with c-Src and the different Sin constructs 
as shown were immunoprecipitated with 
anti-Src mAb327 and immune complexes 
phosphorylated in vitro as in Fig. 3A. Sam­
ples were processed as in Fig. 3A. (C) After 
autoradiography, the nitrocellulose mem­
branes were stripped and reprobed with rab­
bit polyclonal antiserum to GST. 
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5A;B) under conditions where all Sin proteins were 
bound at similar levels (Fig. 5C). The results obtained 
with these proteins on c-Src-induced luciferase activa­
tion could be attributable to GST-induced dimerization 
of the Sin proteins that might have affected the results. 
To examine the possibility, we expressed one of the pro­
teins, SinAC, from the same expession vector as GST-
SinAC but without the GST. This protein activated c-Src 
to the same extent as the GST form when tested in lu­
ciferase assays and coprecipitated with, and was phos-
phorylated by, c-Src in kinase assays (data not shown). 
Therefore, the results shown in Figure 5 do not appear to 
result from GST dimerization. 
Binding of Crk and other phosphoproteins to Sin 
It has been postulated that the tyrosine-containing mo­
tifs on plSO* '^'^  when phosphorylated, can serve as 
"docking sites" for other cytoplasmic SH2-containing 
proteins (Sakai et al. 1994). The potentiation of signaling 
by inclusion of multiple Sin potential SH2-binding sites 
suggested that after phosphorylation by c-Src, Sin also 
may interact with other proteins. The amino-acid resi­
dues DVP carboxy-terminal to the phosphorylated tyro­
sine in a number of the Sin motifs (Table 1) form a po­
tential recognition site for the Crk-SH2 domain because 
this sequence closely matches the predicted high-affinity 
binding site for the Crk-SH2 domain (Songyang et al. 
1993). pl30*^^^ contains numerous YDVP motifs that are 
processively phosphorylated by Abl in a Crk-dependent 
manner (Mayer et al. 1995). Consistent with this, puri­
fied Crk-SH2 binds to Src-phosphorylated plOa-92 in fil­
ter binding assays (Fig. 6A). Therefore, we tested phos­
phorylated plOa-92 and the other Sin derivatives for their 
ability to bind to c-Crk in vivo. We found that the dif­
ferent Sin proteins, as well as the wild-type plOa-92 pep­
tide, formed stable complexes with endogenous Crk 
when 293 cell extracts were immunoprecipitated with 
an antiserum against c-Crk and visualized with an anti-
phosphotyrosine antibody (Fig. 6B, lanes 5, 8-10). The 
mutants of plOa-92 did not bind to Crk (Fig. 6B, lanes 
6,7). The association of the Sin proteins with c-Crk was 
increased greatly by Src coexpression. In the absence of 
Src overexpression, only a small fraction of Sin was de­
tectable in the Crk immunoprecipitates (Fig. 6B, lanes 
15-17). This low level of activity could be attributable to 
the phosphorylation of the Sin proteins by endogenous 
c-Src, evident in the Figure 6C anti-Src immunoblot. In 
addition to the truncated Sin proteins, a large number of 
phosphotyrosine-containing proteins coprecipitated 
with the longer Sin molecules (Fig. 6B, lanes 8-10) but 
not with the peptide that contained only one phospho­
rylated tyrosine (Fig. 6B, lane 5). This suggests that Sin 
can act as a scaffold molecule to which other proteins 
can bind, forming multiprotein complexes that may be 
involved in signaling. It is possible, however, that the 
associated proteins are bound to Crk or another protein 
in the complex. It is unlikely that the multiple bands 
observed with the Sin proteins in the Crk immune com­
plexes are degradation products of Sin because only one 
band is detected in an anti-GST Western blot (Fig. 5B). 
These data suggest that Sin can serve both as an activator 
of c-Src and a downstream effector. In the latter role, 
once phosphorylated by c-Src, Sin could recruit other 
proteins, presumably mainly through SH2 interactions, 
the example being Crk. In this way. Sin could act like 
activated receptor tyrosine kinases, attracting cellular 
SH2-containing molecules to form multiprotein signal­
ing complexes that result in altered cellular behavior. 
Discussion 
We have examined the effect of coordinated binding of 
ligands for the Src-SH3 and Src-SH2 domains on the 
regulation of c-Src enzymatic activity and signaling. 
This study came about from the isolation of a novel pro­
tein. Sin, a relative of p 130'^ ''* that contains sites that can 
interact with Src-SH3 through proline-rich motifs (Al-
exandropoulos et al. 1995). We found that a short region 
of Sin, containing one of the SH3-binding sites as well as 
a single tyrosine, can bind tightly to c-Src. Binding re­
quires that the Sin fragment contains both the SH3-bind-
ing site and the tyrosine, and that c-Src must be catalyt-
ically competent. Binding involves the phosphorylation 
of the tyrosine implying that occupancy of Src-SH3 ac­
tivates the kinase, the kinase phosphorylates the tyro­
sine, and the phosphorylated tyrosine binds to Src-SH2, 
forming a tight complex that can be isolated (Fig. 7B). 
Strikingly, the conditions of forming the stable complex 
are correlated with the activation of signaling. Our read­
out of signaling in vivo is the activation of Src-dependent 
transcription from a luciferase-producing construct. Al­
though the details of the Src-mediated activation of tran­
scription are not known, our data imply that Src signal­
ing can be activated by Sin or a Sin-like protein. 
Sin-activated c-Src could either be activated and signal 
directly through the increased activity of Src kinase and/ 
or could work indirectly, for instance by activating and 
signaling through Crk (Fig. 7C,D). Although direct sig­
naling by Src-mediated phosphorylation of one or more 
targets remains possible, a number of observations sug­
gest that there is an indirect component of the signaling. 
The most telling observation is the increased activity of 
longer Sin constructs. Both Sin and pi30* '^'* have a cen­
tral region that contains multiple tyrosine-containing 
motifs that could serve as SH2-binding sites. We have 
shown that increasing the number of tyrosine-contain­
ing motifs that get phosphorylated by Src correlates with 
increased luciferase activation (Fig. 5) and with binding 
of Crk and other tyrosine-phosphorylated proteins to the 
Sin motifs (Fig. 6). When Sin bound to Crk was isolated, 
many other phosphorylated proteins were seen, although 
Src itself was not present (Fig. 6C). This is the complex 
depicted in Figure 7D. A role for phosphorylated motifs 
acting as "signal assembling" sites for cytoplasmic SH2-
containing proteins has been proposed for pl30^^^ in 
v-Src and v-Crk transformed cells, where expression of 
these oncoproteins correlates with Cas hyperphosphory-
lation and cell transformation (Sakai et al. 1994). Our 
data support the proposed signal assembling role of these 
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Figure 6. Association of phosphorylated Sin 
truncated proteins with c-Crk in vivo. [A] Total 
cell lysates of 293 cells overexpressing c-Src in 
the presence or absence of plOa-92 were frac-
tioned by SDS-PAGE and transferred to nitrocel­
lulose. Membranes were probed with anti-pY 
monoclonal antiserum 4G10 or biotinylated 
GST-Crk-SH2 and GST as indicated. [B] Cell ex­
tracts overexpressing plOa-92 wild-type and mu­
tant peptides and the Sin truncated proteins de­
scribed in Fig. 5 in the presence or absence of 
overexpressed c-Src as indicated, were immuno-
precipitated with anti-Crk monoclonal antibody. 
Proteins were separated by SDS-PAGE, trans­
ferred to nitrocellulose, and immunobloted with 
anti-pY monoclonal antibody. (Lanes 1,2] West-
em blots of untreated (U) 293 cell extracts and 
lysates overexpressing c-Src probed with Src mAb 
327; (lane 3) Western blot probed with anti-Crk 
antiserum, of lysates of untreated cells immuno-
precipitated with anti-Crk antibody. (C) Western 
blots of total cell extracts from B normalized for 
protein content were probed with anti-Src mAb 
327. 
f^ ^ ^ 
p l O a - 9 2 - + + - + 
p l O a - 9 2 
6 
S r c -
H-chain — 
p l O a - 9 2 -
Crk-
+ c - S r c c-Src 
^ 
f^ * * 
o ^ dP^ <; <; cy c^ c^ < > ^ ^ O <t <t <^  <o <yc,^»^ 
- 1 1 2 
- 8 4 
- 5 3 
1 2 3 4 5 6 7 8 9 10 1112 13 1 4 1 5 1 6 1 7 1 8 
S r c -
motifs because a large number of tyrosine-phosphory-
lated cellular proteins coprecipitated with the phospho­
rylated Sin proteins (Fig. 6), and suggest that normal and 
neoplastic pathv^ays may share common intermediates. 
Signaling specificities of Sin and Cas 
The sequence surrounding the proposed signaling ty­
rosines differ betw^een Cas and Sin (Table 1). The major­
ity of the motifs found on Cas contain amino acids car-
boxy-terminal to the tyrosine that are consistent with an 
Abl- (YXXP) or C rk - (YDXP) SH2 domain preference 
(Songyang et al. 1993, Mayer et al. 1995), whereas the 
motifs found on Sin are more diverse. We found that the 
YDVP motif of plOa-92 interacts with endogenous Crk 
in vivo, and binds to Crk-SH2 in vitro (Fig. 6). In con­
trast, incubating cell extracts overexpressing c-Abl and 
plOa-92 with anti-Abl mAb showed no association of 
Abl with the plOa-92 peptide (Fig. 3A), data that support 
a YDVP/Crk-SH2 interaction. Additional motifs that 
are unique to Cas and Sin may reflect signaling specifity 
in a stimulus- or tissue-specific manner by binding to 
distinct subsets of signaling intermediates. Consistent 
with this, the expression patterns of Cas and Sin differ; 
whereas Cas is expressed in many adult tissues (Sakai et 
al. 1994), Sin expression is low and is restricted to the 
brain, thymus, and skeletal muscle (data not shown; Ish-
ino et al. 1995). In addition, Sin contains a tyrosine mo­
tif, YAAP—not present on pi30*^^^—that serves as a high 
affinity ligand for the Abl kinase (Songyang et al. 1995). 
It is possible that this motif may mediate Sin-Abl inter­
actions in the thymus where both proteins are expressed 
more highly. Low expression of Sin in specific tissues 
and different cell lines may explain why Sin has not been 
recognized previously as a Src-bound protein. For in­
stance, we have not been able to detect endogenous Sin 
in 293 cells in our immunoprecipitation assays. 
The amino-terminal SH3 domains of Cas and Sin were 
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Figure 7. Proposed model of c-Src regulation by Sin and Sin-mediated interactions. [A] c-Src is schematized as inhibited in an 
intramolecular fashion through interactions of the phosphorylated tyrosine 527 with SH2 along with an involvement of SH3. Sin is 
shown with only one SH3- and one SH2-ligand site. [B] Binding of Sin proline-rich motif to the c-Src SH3 disrupts the intramolecular 
inhibition of c-Src and leads to both autophosphorylation at c-Src Y416 and Src-mediated phosphorylation of Sin on multiple tyrosines. 
(C) Activated Src and phosphorylated Sin form a stable complex through a strong interaction between Src-SH3 and the RPLPXXP 
motifs of Sin (R) and weak affinity interaction between Src-SH2 and the phosphorylated tyrosine-containmg motifs of Sin (Y). This 
complex may be able to signal by phosphorylating other Src substrates. These could be brought to the complex by interactions v^th 
the free SH2-ligand sites on Sin. (D) Interaction of Sin with proteins that contain high-affinity SH2 domains for the phosphorylated Sin 
motifs displace Src-SH2 and cause the complex to dissociate. Src can then return to its repressed state presumably through phos­
phorylation of the tyrosine 527 by Csk. The complexes formed by Sin and other cytoplasmic proteins could serve as downstream 
signaling effectors that result in altered gene expression. 
found to be highly homologous by sequence comparison. 
Although the binding specificity of these domains is not 
known, Sin-SH3 may augment c-Src signaling by re­
cruiting some other molecules (i.e., another kinase) to 
the signaling complex. It was shown recently that Cas -
SH3 can bind to the FAK tyrosine kinase (Poke and 
Hanks 1995). We found that the presence of Sin-SH3 on 
SinAC augmented c-Src-mediated luciferase activation 
(Fig. 5A). This suggests that the SH3 domain of Sin, as 
well as some of the tyrosine-containing motifs, such as 
YAAP, may act to attract other proteins, possibly ki­
nases such as FAK and Abl, to the complex formed by the 
longer fragments of Sin. Such recruitment of kinases to 
the Sin-Crk complex and subsequent phosphorylation of 
proteins already bound to Sin, could represent an impor­
tant signaling pathway. 
Cas and Sin in cell adhesion 
A mechanism of interaction similar to that described 
here has been proposed with Fyn and Src and the p62-
Sam68 protein (Richard et al. 1995; Taylor 1995; Weng et 
al. 1995; Lock et al. 1996). This protein contains multi­
ple class II SH3-domain ligands as well as many tyrosine-
containing motifs at the carboxyl terminus, properties 
reminiscent of those of Cas and Sin, except that Cas and 
Sin contain only one or two class I ligands, respectively. 
Similarly, cortactin, paxillin, and c-Cbl also contain 
multiple ligands for SH2 and SH3 domains. The insulin 
receptor substrate IRS-1 contains 20 potential tyrosine-
phosphorylation sites that have been proposed to recruit 
SH2-containing proteins that enable IRS-1 to act as a 
docking protein (Sun et al. 1991, 1993; Lee et al. 1993; 
Skolnik et al. 1993). A recently characterized Grb-2-as-
sociating protein, Gab-1, is homologous to IRS-1 and was 
shown to bind several SH2-containing proteins. Overex-
pression of Gab-1 enhanced cell growth and resulted in 
transformation. Therefore, the existence of these pro­
teins defines a new class of molecules that mediate re­
ceptor (Holgado-Madruga et al. 1996) and nonreceptor 
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tyrosine kinase signaling (this paper) by acting as signal 
assemblers (this paper; Sakai et al. 1994) or signal inte­
grating sites that form multiprotein complexes by bind­
ing to distinct adapter molecules and other cytoplasmic 
proteins that in turn serve as downstream effectors. The 
differences in recruiting different combinations of 
adapter molecules through SH2-mediated interactions, 
as well as the presence of the different types of SH3 
ligands, for example, class I verus class II, may reflect 
signaling specificity. 
Recent reports suggest that plSO* '^"'* may be involved 
in integrin-receptor signaling, because integrin-mediated 
cell adhesion promotes tyrosine phosphorylation of Cas 
(Nojima et al. 1995; Vuori and Ruoslahti 1995). It has 
also been shown that integrin-mediated cell adhesion in­
duces autophosphorylation of FAK and subsequent bind­
ing of c-Src to FAK, through interaction of the FAK au­
tophosphorylation site Y-397 and the Src-SH2 domain 
(Schlaepfer et al. 1994). Therefore, it is likely that Cas 
and Sin may modulate c-Src activity in response to ex­
tracellular stimuli, such as interactions of the extracel­
lular matrix with integrin receptors, where Sin may act 
as tissue-specific modulator of cell adhesion. Because the 
Src-SH3 ligand of Sin can interact with the SH3 domains 
of Fyn, Lyn, and Hck as well as SH3 of neuronal Src 
(Alexandropoulos et al. 1995), and its expression is re­
stricted to the brain and thymus (K. Alexandropoulos 
and D. Baltimore, unpubl., Ishino et al. 1995), it is pos­
sible that Sin interacts with Src-related kinases in lym­
phocytes to modulate cell-adhesion events in response to 
lymphocyte-activating signals, or it may interact with 
neuronal Src to modulate LI-mediated neuronal out­
growth, because Src has been shown to mediate such 
processes (Ignelzi et al. 1994). 
Cas and FAK have been shown to be phosphorylated in 
v-Src transformed cells and this phosphorylation is inde­
pendent of cell adhesion (Schlaepfer et al. 1994; Vuori 
and Ruoslahti 1995). Because cell transformation by 
v-Src correlates with increased cellular tyrosine phos­
phorylation and anchorage-independent growth, Cas and 
FAK appear to be involved in the process of anchorage 
dependence. In this report, we show that Sin can induce 
its own phosphorylation by wild-type c-Src in a Src-SH3-
dependent manner. It therefore appears that wild-type 
and transforming Src molecules can utilize the same sig­
naling intermediates to modulate cellular processes, in 
which case c-Src activation would be subject to regula­
tion by external stimuli, whereas v-Src, having escaped 
regulation, would be constitutively active and therefore 
transforming. Correlation of neoplastic pathways to 
physiological processes may provide insight into the 
physiological role of nonreceptor tyrosine kinases that 
will help develop strategies to block the transforming 
activities of deregulated protein tyrosine kinases. 
Materials and methods 
Library screening 
A 16-day mouse embryo expression library (Novagen) was 
screened for SH3-binding proteins according to the manufacter-
er's protocols and as described previously (Cicchetti et al. 1992; 
Alexandropoulos et al. 1995). Biotinylated GST-SH3 fusion pro-
tems of c-Abl, c-Src, c-Crk, and neuronal Src were used as 
probes to screen the library. Positive phage plaques were puri­
fied and recombinant phage were converted into plasmids 
through Cre-mediated excision from XEXlox by plating phage 
with the appropriate host. Recombinant plasmids (pEXlox) con­
taining sequences that bound to the Src-SH3 were then trans­
formed into competent bacteria (Novagen) that permitted ex­
pression of the cloned cDNAs as fusion proteins of gene 10 of 
phage T7. A 5' 400-bp fragment of clone 10a (1.4 kb) that was 
initially isolated (Alexandropoulos et al. 1995), was used to 
screen the same library for a full-length cDNA clone according 
to the manufacterer's protocols. The longest cDNA isolated 
contained a 2.2-kb cDNA piece that encoded for full-length Sin. 
Cells and antibodies 
Human embryonic kidney carcinoma 293 cells (Pear et al. 1993) 
were grown in Dulbecco's modified Eagle medium (DMEM) 
containing 10% fetal bovine serum, 100 U/ml of penicillin, and 
100 mg/ml of streptomycin. Rabbit polyclonal antibodies to 
tyrosine 416 of c-Src (Andy Laudano, University of New Hamp­
shire, Durham! and GST, and mouse monoclonal antibodies 327 
to Src (Joan Brugge, Ariad Pharmaceuticals, Cambridge, MA), 
Crk (Pharmigen), Ab-3 to Abl, and mouse monoclonal anti-pY 
4G10 (UBII were used in this study. 
DNA constructs 
DNA manipulations were performed by standard protocols. 
GST- fusion proteins were produced by plasmids based on the 
pEBG eukaryotic expression vector (Mayer et al. 1995). plOa-92 
wild-type and mutant proteins were expressed as GST-fusion 
proteins by cloning a PCR-amplified fragment of clone 10a (Fig. 
lAl encoding 92 amino acids into the BamHl-Notl sites of 
pEBG. Mutated GST-fusion proteins were derived by PCR, us­
ing mutated synthetic oligonucleotides, and subsequently 
cloned in-frame into the BamHl-Notl sites of pEBG. In addition 
to the NotI restriction site, a translation termination codon was 
included in the 3' oligonucleotide. The construct expressing 
full-length Sin as a GST-fusion protein was constructed by PCR 
amplification of a 1.68-kb fragment (encoding amino acids 
1-560) that was subsequently cloned into the Spel-Notl sites of 
pEBG. Similarly, PCR-amplified DNA fragments expressing 
GST-SinAC (amino acids 1-335) and GST-Sin-SR (amino acids 
68-335) were cloned into the Spel-Notl sites of pEBG. Con­
structs for prokaryotic expression of wild-type and mutant 
plOa-92 GST-fusion proteins were prepared by cloning PCR-
amplified fragments into the BflmHI-£coRI of GEX2T (Pharma­
cia). plOa-18 was cloned as described previously (Alexandropou­
los et al. 1995). The luciferase reporter construct was con­
structed by cloning a Hindlll-Bgill 297-bp fragment from 
pE425-250TKCAT (Qureshi et al. 1991) containing -425/ 
- 250 upstream regulatory sequences of the Egr-1 promoter and 
the herpes simplex virus thymidine kinase (HSV-tk) minimal 
promoter into Hindlll-Bgill-digested pXP-2 luciferase construct 
(Nordeen, 1988). Plasmids that expressed wild-type Src protein 
pM5HHB5, psrc527, and psrcR295 have been described 
(Kmiecik and Shalloway 1987). The construct expressing c-Abl 
has been described (Ben-Neriah et al. 1986). 
Transfections 
293 cells (2x10^ per 60mm dish) were plated 16-20 hr before 
transfection. DNA was transiently introduced into cells by cal-
1352 GENES & DEVELOPMENT 
 Cold Spring Harbor Laboratory Press on April 22, 2020 - Published by genesdev.cshlp.orgDownloaded from 
Sin-induced c-Src activation and signaling 
cium phosphate-mediated transfection as described (Pear et al. 
1993). Two micrograms of each pM5HHB5(c-Src), pcsrcF527, 
pcsrcR295, expressing vectors (Kmiecik and Shalloway 1987), or 
pEVX empty vector were used in all transfections. Transfection 
mixtures also included 1 (xg of wild-type and mutant plOa-92 
constructs and plOa-18 as indicated in the figures. Serum re­
sponse element (SRE)-luciferase reporter DNA and the MFG-
lacZ plasmid expressing p-galactosidase (1 \i.g each) were also 
included in the transfection mixtures. When necessary, the to­
tal amount of DNA in each transfection mixture was kept con­
stant by the addition of empty vector DNA (pEVX) as carrier. 
Each plate was treated with 0.5 ml of DNA-calcium phosphate 
coprecipitate. After 18 hr of incubation at 37°C, the medium 
was replaced and incubation was continued for 24 hr. Cells were 
lysed and extracts were either assayed for luciferase activity 
using a Promega kit according to the manufacturer's protocol, or 
assayed for ^-galactosidase activity to normalize for transfec­
tion efficiency between the different samples according to stan­
dard protocols (Sambrook et al. 1989). Transfections for cell 
extracts used in immunoprecipitation and in vitro kinase assays 
were performed the same way except that cells were lysed in 
NP-40 lysis buffer. 
Immunopiecipitations 
Cells were lysed in 1 ml of ice-cold lysis buffer [1% NP-40, 20 
mM Tris-HCl (pH 8.0), 150 mM NaCl, 10% glycerol, 10 mM NaF, 
1 mM sodium orthovanadate, 1 mM phenylmethylsulfonyl flu­
oride, 10 jJLg/ml of aprotinin, 10 |xg/ml of leupeptin] and incu­
bated on ice for 10 min. The cell debris and nuclei were removed 
by centrifugation in an Eppendorf centrifuge for 10 min at 4°C. 
The cell lysates were then incubated with the specified anti­
body at concentrations suggested by the manufacturers for 2 hr 
at 4°C. The immune complexes were collected after the addi­
tion of 20 |xl of protein G-plus/protein A (Oncogene Science) 
agarose and incubation at 4°C for 30 min. The pellets of agarose 
beads were washed three times with 1 ml of lysis buffer and 
then subjected to kinase reactions in vitro or immunoblotting. 
Kinase reactions 
Protein complexes obtained by immunoprecipitation were 
washed three times in kinase buffer and reactions were carried 
out in 20 \il of buffer containing 20 mM HEPES at pH 7.4, 5 mM 
MnClj, 10 J^LM ATP, and 1 \x\ of [^-^^PIATP (7000 Ci/mmole) 
(ICN), at room temperature for 10 min. The pellets were resus-
pended in 1 x Laemmli buffer, boiled for 2 min, and phospho-
rylated proteins were analyzed by SDS-PAGE and autoradiogra­
phy. 
Western blot analysis 
Total cell extracts normalized for protein content or immuno-
precipitates were boiled in Laemmli sample buffer, electropho-
retically separated on 10% SDS-PAGE, and transferred to nitro­
cellulose membranes. Filters were blocked in TEST buffer (10 
mM Tris-HCl at pH 8.0, 150 mM NaCl, 0.05% Tween 20) plus 
2% nonfat dry milk. Filters were blotted with the appropriate 
monoclonal antiserum at concentrations suggested by the man­
ufacturers in TBST/milk at room temperature for 2 hr. Rabbit 
polyclonal antibodies to GST and anti-pY416 were used at 1:500 
and 1:1000 dilutions, respectively. The filters were washed in 
TEST, and consequently incubated with anti-mouse IgG-conju-
gated horseradish peroxidase at a 1:4000 dilution in TEST at 
room temperature for 1 hr. Filters were then washed and devel­
oped with ECL (Amersham), as described by the manufacturer. 
Filter binding assay 
Src-SH3 and Crk-SH2 binding to plOa-92 wild type and mutant 
GST fusion proteins purified from bacteria was performed as 
described (Alexandropoulos et al. 1995; Mayer et al. 1991). The 
GST-Src-SH3 and Crk-SH2 biotynilated probes were prepared 
as described (Cicchetti et al. 1991). GST-fusion plOa-92 and 
mutant proteins expressed in bacteria were purified using glu­
tathione-agarose beads as described (Mayer et al. 1991). Eacteria 
cell lysates were prepared as described (Ren et al. 1993). Proteins 
were fractionated by electrophoresis through polyacrylamide 
gels and transferred to nitrocellulose filters that were processed 
as described (Ren et al. 1993). 
Solution-binding assays 
Cell extracts overexpressing c-Src or c-SrcY527F were prepared 
as described above and were either immunoprecipitated with 
Src mAb327, or mixed with 10 fig of GST-plOa-92 or GST-lOg 
purified, bacterially expressed proteins that had been coupled to 
glutathione-agarose beads previously by incubating in binding 
buffer [100 mM EDTA and 1% Triton X in PBS) for 1 hr at 4°C 
with constant rotation. Incubations of coupled beads with cell 
extracts were carried out for 2 hr at 4°C, protein complexes were 
harvested, washed extensively, and subjected to phosphoryla­
tion in vitro as described above. Phosphorylated proteins were 
analyzed by 10% SDS-PAGE and autoradiography of the dried 
gel for 15 min at room temperature. 
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